Skip to main content
ANNX logo

ANNX · Annexon, Inc. · Investor Relations

Track ANNX — free
$3.86 +0.03 (+0.78%) At close · Oct 21
Market Cap
$798.36M
Shares
204.44M
Volume · Oct 21 4.95M Avg daily vol (3M) 3.05M

Press releases and events scraped from the company’s investor relations website. Past events open our own call or event page when we host one; otherwise listings link to the original source.

Past events

Date Event Type
2026-09-10 Cantor Global Healthcare Conference Conference
2026-09-09 Wells Fargo 21st Annual Healthcare Conference Conference
2026-08-12 Q2 FY2026 Earnings conference call (announced in 8-K) Earnings call
2026-08-12 Annexon Virtual Business Update Call Event
2026-06-09 Goldman Sachs 47th Annual Global Healthcare Conference Conference
2026-06-03 Jefferies Global Healthcare Conference Conference
2026-05-13 Bank of America Securities Health Care Conference Conference
2026-04-15 25th Annual Needham Virtual Healthcare Conference Conference
2026-03-18 Annexon In-Person and Virtual KOL Event to Discuss Vonaprument for the Treatment of Geographic Atrophy Event
2026-03-03 TD Cowen 46th Annual Health Care Conference Conference
2026-01-14 44th Annual J.P. Morgan Healthcare Conference Conference
2025-11-19 Jefferies 2025 London Healthcare Conference Conference
2025-09-04 Cantor Global Healthcare Conference Conference
2025-09-03 Wells Fargo Healthcare Conference Conference
2025-08-13 H.C. Wainwright 5th Annual Ophthalmology Virtual Conference Conference
2025-06-04 Jefferies Global Healthcare Conference Conference
2025-03-04 TD Cowen 45th Annual Health Care Conference Conference
2025-01-14 43rd Annual J.P. Morgan Healthcare Conference Conference
2024-12-16 GBS Real-World Evidence Update Event
2024-11-20 Jefferies London Healthcare Conference Conference
2024-09-17 Cantor Global Healthcare Conference Conference
2024-09-04 Wells Fargo Healthcare Conference Conference
2024-06-04 GBS Program Update Event

Source: https://ir.annexonbio.com/

Key facts CIK 1528115 CUSIP 03589W102 13F (30d) 15 filings 15 filers Visit website Investor relations